← Back to Search

Behavioural Intervention

Visual Stimulation for Vision Impairment

N/A
Recruiting
Research Sponsored by University of Alberta
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
All patients 18 years of age or older with a homonymous hemianopsia or quadrantopsia, who can provide informed consent, and communicate in English.
Be older than 18 years old
Must not have
Patients with light-induced seizures are excluded due to the potential triggering effect of flashing lights from the automated perimeter and PowerPoint program.
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights
No Placebo-Only Group

Summary

"This trial will investigate if showing PowerPoint images to patients with hemianopsia (visual field loss) after a stroke or brain injury can help improve their visual field."

Who is the study for?
This trial is for individuals who have lost part of their field of vision, known as hemianopsia, due to a stroke or brain injury. Specific eligibility criteria are not provided.
What is being tested?
The study is testing whether using a PowerPoint program to stimulate the visual field can help improve vision in patients with hemianopsia after a stroke or brain injury.
What are the potential side effects?
Since this intervention involves non-invasive visual stimulation through PowerPoint slides, no significant side effects are expected.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am 18 or older, have partial vision loss, can consent, and speak English.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I do not have seizures triggered by flashing lights.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Visual Field Index on Humphrey perimetry

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Active Control
Group I: Group 2 (PowerPoint program)Active Control1 Intervention
Group 2 with an even number year of birth will be asked to view the 15-minute PowerPoint program three days per week for 2 months.
Group II: Group 1 (online news)Active Control1 Intervention
Group 1 with an odd number year of birth will be asked to view 15 minutes of online news three days per week for 2 months. LIVE: Canadian News \| Weather \& Traffic - Latest Sports \| Breaking News (globalnews.ca)

Find a Location

Who is running the clinical trial?

University of AlbertaLead Sponsor
937 Previous Clinical Trials
433,784 Total Patients Enrolled
~27 spots leftby Dec 2027